Impact of technological developments in drug-eluting stents on patient-focused outcomes: apooled direct and indirect comparison of randomised trials comparing first- and second-generation drug-eluting stents-Reference-Cited by-同舟云学术

Impact of technological developments in drug-eluting stents on patient-focused outcomes: apooled direct and indirect comparison of randomised trials comparing first- and second-generation drug-eluting stents

Published:2014-12 Issue:8 Volume:10 Page:942-952
ISSN:1774-024X
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

Colmenarez Humberto,Fernández Cristina,Escaned Javier

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the “Late Catch-Up” Phenomenon Between BuMA Supreme and XIENCE Stents Through Serial Optical Coherence Tomography at 1–2 Month and 2 Year Follow-Ups: A Multicenter Study;Cardiovascular Innovations and Applications;2024

2. Indirect comparison of nonvitamin K oral anticoagulants and left atrial appendage occlusion;Cardiovascular Prevention and Pharmacotherapy;2022-01-31

3. Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: Insights From a Network Meta-Analysis of Randomized Trials;Cardiovascular Revascularization Medicine;2021-07

4. Death is associated to the type of drug-eluting stent in patients with left ventricular dysfunction and elevated natriuretic peptide levels;Scientific Reports;2021-01-28

5. Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9- to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial;American Heart Journal;2020-10